Uroflowmetry and Nocturnal Enuresis
Is Uroflowmetry Useful in Assessing Response to Pharmacological Treatment in Enuresis
1 other identifier
observational
100
1 country
1
Brief Summary
This study will evaluate the uroflowmetry parameters of patients which were treated for enuresis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedFirst Submitted
Initial submission to the registry
June 11, 2025
CompletedFirst Posted
Study publicly available on registry
June 19, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedJune 24, 2025
June 1, 2025
2 years
June 11, 2025
June 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of days without bedwetting
Achievement of bedwetting in one or less night of a month
1 month
Study Arms (3)
Desmopressin 120mcg
Patients treated with desmopressin 120 mcg
Desmopressin 240 mcg
Patients treated with desmopressin 240mcg
Desmopressin 240 mcg + anticholinergic
Patients treated with desmopressin 240mcg + anticholinergic agent
Interventions
Desmopressin 120 mcg will be used frist-line drug in the treatment of enuresis.
Desmopressin 240 mcg will be used for the patients who have not responsive to desmopressin 120 mcg.
Propiverine (a dose of 0.8 mg/ kg) will be used for the patients who have -response to treatment with desmopressin 240 mcg
Eligibility Criteria
Patients who were treated for enuresis in pediatric urology clinic of Sancaktepe Sehit Prof Dr Ilhan Varank Training and Research Hospital
You may qualify if:
- Presence of enuresis nocturna
- Patients who have uroflowmetry test
You may not qualify if:
- Presence of lower urinary tract symptoms
- Presence of anatomical or neurological problems
- Patients with missing data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sancaktepe Sehit Prof dr Ilhan Varank Training and Research Hospital
Istanbul, Kadikoy, 34000, Turkey (Türkiye)
Related Publications (1)
Kang BJ, Chung JM, Lee SD. Evaluation of Functional Bladder Capacity in Children with Nocturnal Enuresis According to Type and Treatment Outcome. Res Rep Urol. 2020 Sep 15;12:383-389. doi: 10.2147/RRU.S267417. eCollection 2020.
PMID: 32984086BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Medical doctor
Study Record Dates
First Submitted
June 11, 2025
First Posted
June 19, 2025
Study Start
August 20, 2022
Primary Completion
September 1, 2024
Study Completion
December 30, 2025
Last Updated
June 24, 2025
Record last verified: 2025-06